Member Info for Thejam4

Just topped up with another 22 million shares

What are we expecting tomorrow when the majority of the placing share go live, please discuss

I could sell all my 7million all at one go, they want our shares, keep steadfast

Just awoken to this fantastic news

Roca test has been a game changer newly approved, this is all we need!

https://www.channel4.com/news/nhs-offering-new-ovarian-cancer-surveillance-test-for-high-risk-women

A fish supper on me for every share holder if it gets to 40p

The Episwitch is not just for prostrate cancer, it is a new platform/gateway that’s going to revolutionise how disease is detected at the gnome level, so enabling accurate detection of disease

This could explode anytime soon

Https://obdx.co/hjw

Https://www.proactiveinvestors.com/companies/news/1077177/oxford-biodynamics-chair-on-key-collaboration-with-google-cloud.html

Up over 20% now

Looks like a 100k buy

Big buy about to drop

How can you tell there purchases

More bought than sold there just after your shares stay strong

In the UK, nearly 100,000 prostate biopsies are performed annually in the NHS. This number is expected to increase, with some projections suggesting it could double in the next decade, many are false positive or false negative, the cost of the biopsy and subsequent MRI on the NHS is vastly more than the OBD PSE test, not to mention all the other factors stress while waiting for the test/results, freeing up hospital beds, etc

Multibag, just be patient

I’m all in with just over 66million shares

Https://youtu.be/EGh1-fEaiso

Https://www.linkedin.com/posts/linda-kelly-33106011_baus25-ugcPost-7340423897042837505-mF9f?utm_medium=ios_app&rcm=ACoAAAvWZj8BtuUmUf5BR5ZV9XIFWvi6EaNHSxk&utm_source=social_share_send&utm_campaign=copy_link

Major shareholders: Oxford BioDynamics Plc

Name Equities % Valuation

Vulpes Investment Management Pte Ltd.

12.87 %

Unicorn Asset Management Ltd.

7.414 %

Sankofa Strategic Equity Fund Ltd.

6.565 %

Arbuthnot Latham & Co. Ltd.

3.792 %

William Salomon

3.065 %

Hargreaves Lansdown Asset Management Ltd.

2.104 %

Cantor Fitzgerald Europe

2.053 %

IG Markets Ltd.

1.728 %

HSBC Bank Plc (Market-Maker)

1.49 %

KW Investment Management Ltd.

1.259 %